Atlas Trials

A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis

Clinical trial NCT01681953 · COMPLETED

Trial details

NCT number
NCT01681953
Sponsor
Zymenex A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Alpha-Mannosidosis
Start date
2012-08-01
Primary completion
2014-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.